|
Senate Bills - 108th Congress
Session I | Session II
S. 666Biological, Chemical, and Radiological Weapons Countermeasures Research Act
On March 19, 2003, Senator Joseph Lieberman (D-CT) introduced S. 666, the
Biological, Chemical, and Radiological Weapons Countermeasures Research Act.
Provisions would authorize the Director of NIH to award partnership challenge
grants to promote joint ventures between the Agency, its grantees, and for-profit
biotechnology, pharmaceutical, and medical device industries for the development
of countermeasures and research tools. The Director would be required to issue
regulations within 90 days of enactment of the bill to implement the awarding of
these grants. Authorized would be $200 million for each of the FYs 2004 through
2008. S. 666 was referred to the Senate Committee on Finance.
Legislative Update (August 2003):
Biological, Chemical, Radiological, and Nuclear Defense
|
|